What XLV holds
All 62, covering 99.95% of the fund. Weights are the fund's own, as filed.
| # | Company | Weight |
|---|---|---|
| 1 | Eli Lilly & Co | 16.51% |
| 2 | Johnson & Johnson | 10.64% |
| 3 | AbbVie Inc | 7.74% |
| 4 | UnitedHealth Group Inc | 6.57% |
| 5 | Merck & Co Inc | 5.52% |
| 6 | Amgen Inc | 3.40% |
| 7 | Thermo Fisher Scientific Inc | 3.24% |
| 8 | Abbott Laboratories | 2.75% |
| 9 | Gilead Sciences Inc | 2.73% |
| 10 | Intuitive Surgical Inc | 2.45% |
| 11 | Pfizer Inc | 2.39% |
| 12 | CVS Health Corp | 2.30% |
| 13 | Vertex Pharmaceuticals Inc | 2.19% |
| 14 | Danaher Corp | 2.09% |
| 15 | Bristol-Myers Squibb Co | 2.05% |
| 16 | Stryker Corp | 1.89% |
| 17 | Medtronic PLC | 1.75% |
| 18 | McKesson Corp | 1.58% |
| 19 | Elevance Health Inc | 1.46% |
| 20 | Cigna Group/The | 1.27% |
| 21 | Boston Scientific Corp | 1.10% |
| 22 | Regeneron Pharmaceuticals Inc | 1.08% |
| 23 | HCA Healthcare Inc | 1.05% |
| 24 | Cardinal Health Inc | 0.97% |
| 25 | Cencora Inc | 0.96% |
| 26 | Edwards Lifesciences Corp | 0.91% |
| 27 | Humana Inc | 0.83% |
| 28 | Becton Dickinson & Co | 0.73% |
| 29 | IDEXX Laboratories Inc | 0.72% |
| 30 | Agilent Technologies Inc | 0.65% |
| 31 | Waters Corp | 0.64% |
| 32 | IQVIA Holdings Inc | 0.56% |
| 33 | Biogen Inc | 0.56% |
| 34 | Zoetis Inc | 0.52% |
| 35 | Centene Corp | 0.52% |
| 36 | GE HealthCare Technologies Inc | 0.51% |
| 37 | ResMed Inc | 0.49% |
| 38 | Veeva Systems Inc | 0.46% |
| 39 | Dexcom Inc | 0.45% |
| 40 | Mettler-Toledo International Inc | 0.45% |
| 41 | West Pharmaceutical Services Inc | 0.44% |
| 42 | Moderna Inc | 0.43% |
| 43 | Quest Diagnostics Inc | 0.41% |
| 44 | Labcorp Holdings Inc | 0.40% |
| 45 | STERIS PLC | 0.36% |
| 46 | Incyte Corp | 0.33% |
| 47 | Viatris Inc | 0.32% |
| 48 | Zimmer Biomet Holdings Inc | 0.29% |
| 49 | State Street Global Advisors | 0.26% |
| 50 | Cooper Cos Inc/The | 0.24% |
| 51 | Revvity Inc | 0.22% |
| 52 | Solventum Corp | 0.20% |
| 53 | Align Technology Inc | 0.20% |
| 54 | Bio-Techne Corp | 0.19% |
| 55 | Baxter International Inc | 0.19% |
| 56 | Charles River Laboratories International Inc | 0.19% |
| 57 | Insulet Corp | 0.18% |
| 58 | Henry Schein Inc | 0.14% |
| 59 | Universal Health Services Inc | 0.14% |
| 60 | DaVita Inc | 0.12% |
| 61 | Chicago Mercantile Exchange | 0.01% |
| 62 | CONTRA HOLOGIC INCORPO | 0.00% |
Where the money sits
Sector weights as supplied by our market data provider, covering 100.00% of the fund.
| Sector | Weight |
|---|---|
| Health Care | 100.00% |
Dividend history
XLV pays a dividend every quarter. Over the last twelve months that came to USD 3.18 per share. Over five years the yearly payout grew 7.96% a year.
| Year | Dividends per share |
|---|---|
| 2026 (so far) | USD 1.89 |
| 2025 | USD 2.48 |
| 2024 | USD 2.29 |
| 2023 | USD 2.17 |
| 2022 | USD 1.99 |
| 2021 | USD 1.87 |
| 2020 | USD 1.69 |
| 2019 | USD 2.21 |
| 2018 | USD 1.36 |
| 2017 | USD 1.22 |
Per share, in the currency the fund pays in, adjusted for later splits so the years compare like for like.
Compared with other funds
Holdings and the reporting date come from the fund's own Form N-PORT filing with the SEC. Expense ratio, dividend yield, dividend history and sector weights come from our market data provider. Nothing on this page is estimated: a holding the filing did not report is not shown.